NewtekOne Repositions Earnings Guidance with an Emphasis on Recurring Net Interest Income

NewtekOne raised/updated its outlook, now guiding 2026 EPS to $1.70–$1.80 and 2027 EPS to $2.00–$2.20. The EPS path is attributed to holding more guaranteed SBA 7(a) loan portions on-balance-sheet, shifting revenue mix toward net interest income (NII), which is expected to grow faster than noninterest income. This guidance update should be supportive for investor expectations around NII contribution.

Analysis

The key mechanism is a shift from fee/transaction income toward spread income, which usually looks cleaner on the P&L but consumes more balance-sheet capacity. In the near term that can support earnings quality and reduce quarter-to-quarter volatility, yet it also ties NewtekOne more tightly to funding costs and deposit competition; if liabilities reprice faster than SBA assets, the upside to NII can compress quickly. That makes this more of a margin-management story than a pure growth story.

Second-order, the move implies a slower capital velocity model: retaining more guaranteed paper should lift reported assets and NII, but likely lowers the economic ROE on each originations dollar versus an originate-and-sell mix. If investors focus only on higher EPS, they may miss the possibility of lower fee leverage and a more balance-sheet-intensive profile, which could deserve a lower multiple unless deposit growth and tangible book compounding stay strong. For peers, a stickier hold strategy can marginally support secondary-market SBA paper pricing and may pressure nonbank originators that rely on sale premiums to hit targets.

The contrarian risk is that the market treats this as a straightforward raise without asking whether the change is durable. If funding costs rise, or if management later reverts to selling more of the guaranteed portion to manage capital, the NII inflection can fade within 1-2 quarters. The thesis would be falsified if next updates show NIM compression, weaker originations, or slower tangible book growth despite the higher earnings guide.

Key Decisions for Investors

• Buy NEWT on any post-announcement weakness as a 1-3 month tactical long; expect a modest rerating if the market starts to value the business more like a recurring-NII lender, but keep position size small because the model is still funding-sensitive.
• If liquid enough, use a 3-6 month call spread on NEWT rather than stock to express the rerating thesis with defined downside; the payoff improves if NII stabilization drives a multiple expansion before the market fully prices in the balance-sheet build.
• Do not chase the headline EPS upgrade if funding data deteriorates; set a hard alert for any rise in deposit beta, NIM compression, or a reversal in the mix shift, since those would quickly undercut the thesis.
• Watch SBA secondary-market pricing and peer origination commentary over the next 1-3 quarters; if holding paper becomes a broader industry trend, it could support valuations for existing SBA pools while squeezing originators that depend on sale premiums.